NSUP
PFE icon

NLB Skladi upravljanje premozenja’s Pfizer PFE Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Sell
163,956
-10,142
-6% -$265K 0.15% 117
2026
Q1 		$4.89M Sell
174,098
-49,000
-22% -$1.3M 0.23% 99
2025
Q4 		$5.56M Buy
+223,098
New +$5.63M 0.25% 88

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NLB Skladi upravljanje premozenja's PFE Position: Q2 2026 in Review

NLB Skladi upravljanje premozenja reduced its Pfizer (PFE) stake by 5.8% in Q2 2026, selling an estimated $265K and leaving 163,956 shares worth $3.95M. The position accounts for 0.15% of the portfolio, ranked #117.

NLB Skladi upravljanje premozenja first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.56M in Q4 2025. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • NLB Skladi upravljanje premozenja held 163,956 shares of Pfizer worth $3.95M as of Q2 2026.
  • NLB Skladi upravljanje premozenja sold 10,142 Pfizer shares in Q2 2026, an estimated $265K.
  • Pfizer made up 0.15% of NLB Skladi upravljanje premozenja's portfolio in Q2 2026, its #117 holding.
  • NLB Skladi upravljanje premozenja first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • NLB Skladi upravljanje premozenja's Pfizer position peaked at $5.56M in Q4 2025.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q2 2026, filed 6 Aug 2026.